Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q3 2023 ▲▼ | Q4 2023 ▲▼ | Change ▲▼ | Q3 2023 ▲▼ | Q4 2023 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| BridgeBio Pharma, Inc.(BBIO) | 6,068,125 | 6,068,125 | 0 | $160.02M | $244.97M | 73.07% | +$84.95M |
| Verona Pharma plc (VRNA)ADS | 1,115,352 | 1,115,352 | 0 | $18.18M | $22.17M | 6.61% | +$3.99M |
| Syndax Pharmaceuticals, Inc.(SNDX) | 1,025,000 | 1,025,000 | 0 | $14.88M | $22.15M | 6.61% | +$7.27M |
| Biomea Fusion, Inc.(BMEA) | 798,757 | 798,757 | 0 | $10.99M | $11.60M | 3.46% | +$607.1K |
| COMPASS Pathways plcADS(CMPS) | 964,500 | 964,500 | 0 | $7.14M | $8.44M | 2.52% | +$1.30M |
| Monte Rosa Therapeutics, Inc.(GLUE) | 1,472,331 | 1,472,331 | 0 | $7.05M | $8.32M | 2.48% | +$1.27M |
| Nuvation Bio Inc.CL A(NUVB) | 2,541,009 | 2,541,009 | 0 | $3.40M | $3.84M | 1.14% | +$432.0K |
| Spruce Biosciences, Inc. (SPRB) | 1,205,511 | 1,205,511 | 0 | $2.72M | $3.53M | 1.05% | +$807.7K |
| Poseida Therapeutics Inc. (PSTX) | 1,043,267 | 1,043,267 | 0 | $2.48M | $3.51M | 1.05% | +$1.02M |
| Marker Therapeutics, Inc.(MRKR) | 314,286 | 314,286 | 0 | $1.43M | $1.73M | 0.52% | +$301.7K |
| Elevation Oncology Inc (ELEV) | 2,834,910 | 2,834,910 | 0 | $1.88M | $1.52M | 0.45% | -$356.1K |
| Reneo Pharmaceuticals Inc (RPHM) | 886,075 | 886,075 | 0 | $6.74M | $1.42M | 0.42% | -$5.33M |
| Avrobio, Inc. (AVRO) | 1,009,779 | 1,009,779 | 0 | $1.56M | $1.37M | 0.41% | -$181.8K |
| Aclaris Therapeutics, Inc.(ACRS) | 434,455 | 434,455 | 0 | $2.98M | $456.2K | 0.14% | -$2.52M |
| Viracta Therapeutics Inc (VIRX) | 288,571 | 288,571 | 0 | $300.1K | $164.5K | 0.05% | -$135.6K |
| Atreca Inc. (BCEL)CL A | 387,653 | 387,653 | 0 | $101.2K | $51.2K | 0.02% | -$50.0K |
| Aeglea Biotherapeutics Inc (AGLE)COM NEW(SYRE) | 67,645 | 0 | -67,645 | $828.7K | $0 | — | -$828.7K |